EP2650381
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.7.2008EP published:
21.9.2016EP application number:
13167177.8
EPO information:
European Patent Register
Max expiry date:
30.7.2028
Title:
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
Timeline
Today
31.7.2008EP application
21.9.2016EP Publication
Owner
Name:
Accera, Inc.Address:
380 Interlocken Crescent, Suite 780, 80021, Broomfield, Colorado, US
Inventor
Name:
Henderson, Samuel T.Address:
Golden, CO, US
Priority
Number:
953074 PDate:
31.7.2007Country:
US
Classification
Categories:
C12Q 1/68, A61K 31/23, A61K 31/7004